29 Jan, 2019
Berkeley lifted fiscal profit outlook. Fresenius issued a profit warning. Carl Zeiss Meditec profit declined 7% but revenues surged 8%. Fresenius Medical Care forecasted solid revenue growth in fiscal 2018.
In London trading, FTSE 100 index soared 145.13 or 2.2% to 6,847.93 and in Frankfurt the DAX index advanced 105.46 or 0.9% to 10,912.50.
In Paris, CAC 40 index jumped 87.85 or 1.8% to 4,867.92.
Berkeley Group Holdings Plc, advanced 2.3% to 3,396 pence after the U.K.-based property developer reported revenues in the first-half ending in October dropped 0.7% from a year ago to £1.6 billion.
Net income in the period plunged 25.8% to £325.1 million from £438.4 million in a year ago period and diluted earnings per share slumped to 240 pence from 312 pence.
The home builder forecasted fiscal 2019 pretax profit of 5% and unchanged for the next two years.
Carl Zeiss Meditec AG, rose 0.5% to €66.45 after Germany-based medical devices maker said revenues in the nine-month period ending in September soared 7.6% from a year ago to €1.3 billion.
Net profit in the period declined 7.1% to €126.2 million from €135.8 million in a year ago period and diluted earnings per share dropped to €1.41 from €1.57.
Carl Zeiss said revenues in the ophthalmic devices business jumped 6% to €933.3 million and revenues in the microsurgery segment surged 12.3% to €347.6 million.
The medical devices maker forecasted fiscal 2018 operating profit between 14% and 16%.
Fresenius Medical Care AG & Co. KGaA, plunged 7.4% to €63 after Germany-based dialysis care and services provider forecasted fiscal 2019 solid revenue growth and flat net income from the same period a year ago.
Fresenius Medical schedule to publish its revised estimate along with its fiscal 2018 results on February 20, 2019.